Wells Fargo’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-108
| Closed | -$117 | – | 7034 |
|
|
2024
Q1 | $117 | Buy |
108
+2
| +2% | +$2 | ﹤0.01% | 6224 |
|
|
2023
Q4 | $58 | Buy |
106
+6
| +6% | +$3 | ﹤0.01% | 6457 |
|
|
2023
Q3 | $211 | Buy |
100
+19
| +23% | +$40 | ﹤0.01% | 6192 |
|
|
2023
Q2 | $212 | Buy |
81
+3
| +4% | +$8 | ﹤0.01% | 6377 |
|
|
2023
Q1 | $247 | Buy |
78
+1
| +1% | +$3 | ﹤0.01% | 6396 |
|
|
2022
Q4 | $207 | Buy |
77
+2
| +3% | +$5 | ﹤0.01% | 6286 |
|
|
2022
Q3 | $0 | Buy |
75
+24
| +47% | – | ﹤0.01% | 7145 |
|
|
2022
Q2 | $0 | Sell |
51
-1,612
| -97% | – | ﹤0.01% | 7257 |
|
|
2022
Q1 | $12K | Sell |
1,663
-2,799
| -63% | -$20.2K | ﹤0.01% | 5866 |
|
|
2021
Q4 | $71K | Buy |
+4,462
| New | +$71K | ﹤0.01% | 5375 |
|